Staphylococcus aureus plays an important role in the pathogenesis and course of atopic dermatitis. Compared to the normal pediatric population, atopic patients are especially susceptible to colonization and recurrent infections of S aureus.
Older non-specific immunomodulatory drugs and off-label use of several biologic agents offer treatment options for children with severe atopic dermatitis (AD). However, the future should bring therapies specifically developed for treatment of AD investigated in children.
Patients with moderate to severe atopic dermatitis (AD)—or eczema—may be successfully treated using a rheumatoid arthritis (RA) drug recently shown to reverse 2 other skin conditions, vitiligo and alopecia areata, according to findings published early online in the Journal of the American Academy of Dermatology.
In part two of our discussion, Kelly Cordoro, M.D., associate professor of dermatology and pediatrics at the University of California in San Francisco, discusses environmental and microbial triggers and when to choose systemic therapies with Dermatology Times editorial advisor, Elaine Siegfried, M.D.
Probiotics, which are helpful bacteria that protect the body from harmful bacteria, are literally everywhere. In light of increasing antibiotic resistance due to over- and misuse, coupled with patients’ preferences for more holistic, natural approaches to healing, are we entering an era of anti-antibiotics and pro-probiotics?
Although many systemic immunomodulators are approved for psoriasis, their mechanisms of action suggest they have utility in indications ranging from atopic dermatitis (AD) to chronic urticaria. Understanding a systemic immunomodulator’s mechanism of action provides a theoretical basis for uses beyond its labeled indication.
To determine the utility of food allergy panel testing among patients referred to a pediatric food allergy center, investigators conducted a retrospective chart review of such patients for whom a primary care provider had obtained a standard panel of immunoglobulin E (IgE) tests.